Showing results (3551-3560 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 29, 2003
Phospholipid analogs against HIV-1 infection and diseaseSusan L Morris-Natschke, Khalid S Ishaq, Louis S KuceraCurrent Pharmaceutical Design|May 29, 2003
Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41Li Huang, Linda Zhang, Chin Ho ChenCurrent Pharmaceutical Design|May 29, 2003
Ghrelin as a potential anti-obesity targetTamas L Horvath, Tamara Castañeda, Mads Tang-Christensen, et al.Current Pharmaceutical Design|May 29, 2003
Acylation stimulating protein and triacylglycerol synthesis: potential drug targets?K CianfloneCurrent Pharmaceutical Design|May 29, 2003
Opioid receptor ligands derived from food proteinsH TeschemacherCurrent Pharmaceutical Design|May 29, 2003
Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonistsAmbikaipakan BalasubramaniamCurrent Pharmaceutical Design|May 29, 2003
Therapeutically-induced autoantibodies in patients treated with recombinant hematopoietic growth factors: a brief summaryTakashi Kato, Hiroshi MiyazakiCurrent Pharmaceutical Design|May 29, 2003
Clinical trials targeting advanced cancers by active immunization of T-cell defined tumor antigensHideyuki IkedaCurrent Pharmaceutical Design|March 14, 2008
Chemical origins of isoform selectivity in histone deacetylase inhibitorsKyle V Butler, Alan P KozikowskiCurrent Pharmaceutical Design|March 14, 2008
Fibrate-associated adverse effects beyond muscle and liver toxicityM Florentin, E N Liberopoulos, D P Mikhailidis, et al.Pageof 1,008